IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3⁺ regulatory T cells
The conditions leading to the induction of adaptive Foxp3⁺ regulatory T cells (T-regs) from peripheral T cells in vivo are incompletely understood. Here, we show that unresponsiveness of T cells to IL-6 by T cell-selective deletion of gp130 or immunization of wild-type mice with antigen in incomplet...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 105; no. 47; pp. 18460 - 18465 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
25.11.2008
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The conditions leading to the induction of adaptive Foxp3⁺ regulatory T cells (T-regs) from peripheral T cells in vivo are incompletely understood. Here, we show that unresponsiveness of T cells to IL-6 by T cell-selective deletion of gp130 or immunization of wild-type mice with antigen in incomplete Freund's adjuvant (IFA), which fails to induce IL-6, promotes the conversion of peripheral CD4⁺ T cells into adaptive Foxp3⁺ T-regs. Thus, both T cell-conditional gp130 knockout (KO) mice immunized with MOG35-55 in complete Freund's adjuvant (CFA) and wild-type mice immunized with MOG35-55 in IFA develop overwhelming antigen-specific T-reg responses and are protected from experimental autoimmune encephalomyelitis (EAE). Depletion of T-regs restores T helper (Th)17 responses and clinical EAE in MOG/CFA-immunized T cell-conditional gp130 KO mice, but not in MOG/IFA-immunized wild-type mice. We conclude that in the absence of T-regs, IL-6 signaling is dispensable for the induction of Th17 cells, and alternative pathways exist to induce Th17 cells and EAE in the absence of IL-6 signaling. However, IL-6 signaling is dominant in inhibiting the conversion of conventional T cells into Foxp3⁺ T-regs in vivo, and in the absence of IL-6 signaling, no other cytokine can substitute in inhibiting T-reg conversion. These data identify IL-6 as an important target to modulate autoimmune responses and chronic inflammation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Communicated by Laurie H. Glimcher, Harvard School of Public Health, Boston, MA, October 2, 2008 2A.W. and V.K.K. contributed equally to this work. Author contributions: T.K., A.W., V.K.K., and M.O. designed research; T.K., M.M., A.L.C., A.A., V.A.D., and G.G. performed research; G.L.S. and M.H.K. contributed new reagents/analytic tools; T.K., M.M., P.V., and M.O. analyzed data; and T.K. wrote the paper. 1T.K. and M.M. contributed equally to this work. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0809850105 |